CLINICAL TRIALS
Active clinical trials and verified researcher listings for Obesity, simplified into plain English.
ABOUT OBESITY
Obesity is a medical condition, considered a disease by multiple organizations, in which excess body fat has accumulated to such an extent that it can have negative effects on health. People are classified as obese when their body mass index (BMI)—a person's weight divided by the square of the person's height—is over 30 kg/m2; the range 25–30 kg/m2 is defined as overweight. Some East Asian countries use lower BMI thresholds to define obesity. Obesity is a major cause of disability and is correlated with various diseases and conditions, particularly cardiovascular diseases, type 2 diabetes, obstructive sleep apnea, certain types of cancer, and osteoarthritis.
Source: Wikipedia. For educational use only — not medical advice.
ACTIVELY RECRUITING TRIALS
COMMON QUESTIONS
Are there clinical trials currently recruiting for Obesity?
Yes. This page displays actively recruiting Obesity clinical trials sourced in real time from ClinicalTrials.gov. Use the filters to narrow by phase, status, and location.
How do I join a clinical trial for Obesity?
Browse the trials listed above, review the eligibility criteria for each study, and submit a contact request directly to the research team. You can also speak to your physician about a referral.
Are Obesity clinical trials free to participate in?
Most clinical trials cover the cost of the investigational treatment and all study-related visits. Some studies also offer compensation for time and travel. Always confirm costs and insurance coverage with the trial coordinator before enrolling.
What eligibility requirements apply to Obesity trials?
Requirements vary by study. Common criteria include a confirmed Obesity diagnosis, age range, prior treatments, and general health status. Each trial listing shows its specific inclusion and exclusion criteria.
What phases of Obesity trials are available?
Obesity trials span Phase I (safety testing), Phase II (effectiveness), Phase III (comparison to standard care), and Phase IV (post-approval monitoring). Phase II and III trials are most commonly open to new participants.
RELATED CONDITIONS